Biora Therapeutics (FRA:4ZU0) Price-to-Operating-Cash-Flow : (As of May. 31, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biora Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-05-31), Biora Therapeutics's share price is €0.57. Biora Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.42. Hence, Biora Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Biora Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:4ZU0's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.32
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Biora Therapeutics's Cash Flow from Operations per share for the three months ended in Mar. 2024 was €-0.39. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.42.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 72.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 31.10% per year.

During the past 6 years, Biora Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 72.70% per year. The lowest was -40.80% per year. And the median was 10.30% per year.

Biora Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Biora Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biora Therapeutics Price-to-Operating-Cash-Flow Chart

Biora Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Biora Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Biora Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Biora Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biora Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biora Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biora Therapeutics's Price-to-Operating-Cash-Flow falls into.

Biora Therapeutics Price-to-Operating-Cash-Flow Calculation

Biora Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.57	/	-2.416
	=

Biora Therapeutics's Share Price of today is €0.57.
Biora Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.42.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Biora Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Biora Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Biora Therapeutics (FRA:4ZU0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biora Therapeutics Inc (FRA:4ZU0) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BIOR:USA 4ZU0:Germany

Address

4330 La Jolla Village Drive, Suite 300, San Diego, CA, USA, 92122

Website

https://www.bioratherapeutics.com

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology. Geographically, it operates only in the United States.

Biora Therapeutics (FRA:4ZU0) Headlines

No Headlines